12-80320530-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001378609.3(OTOGL):c.3911A>T(p.His1304Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000799 in 1,613,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.3911A>T | p.His1304Leu | missense_variant | Exon 34 of 59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.3911A>T | p.His1304Leu | missense_variant | Exon 34 of 59 | 5 | NM_001378609.3 | ENSP00000447211.2 | ||
OTOGL | ENST00000646859.1 | c.3776A>T | p.His1259Leu | missense_variant | Exon 38 of 63 | ENSP00000496036.1 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000110 AC: 27AN: 246270Hom.: 0 AF XY: 0.0000897 AC XY: 12AN XY: 133822
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461350Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 726936
GnomAD4 genome AF: 0.000466 AC: 71AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
This sequence change replaces histidine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 1295 of the OTOGL protein (p.His1295Leu). This variant is present in population databases (rs187723280, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with OTOGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 229119). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.His1295Leu va riant in OTOGL has not been previously reported in individuals with hearing loss , but has been identified in 0.2% (15/9632) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs187723280) . Computational prediction tools and conservation analysis suggest that this var iant may not impact the protein, though this information is not predictive enoug h to rule out pathogenicity. In summary, while the clinical significance of the p.His1295Leu variant is uncertain, its frequency suggests that it is more likely to be benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at